INHIBIGENS

Serial Number 88797352
Registration 6398491
700

Registration Progress

Application Filed
Feb 14, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered
Jun 22, 2021

Trademark Image

INHIBIGENS

Basic Information

Serial Number
88797352
Registration Number
6398491
Filing Date
February 14, 2020
Registration Date
June 22, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 22, 2021
Registration
Registered
Classes
044

Rights Holder

ICHOR MEDICAL SYSTEMS, INC.

03
Address
6310 NANCY RIDGE DRIVE, SUITE 107
SAN DIEGO, CA 92121

Ownership History

Genocea Biosciences, Inc.

Original Applicant
03
Cambridge, MA

Genocea Biosciences, Inc.

Original Registrant
03
Cambridge, MA

ICHOR MEDICAL SYSTEMS, INC.

New Owner After Registration #1
03
SAN DIEGO, CA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
551 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20210622)
Due Date
June 22, 2027
Grace Period Ends
December 22, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Jan 4, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 22, 2021 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
May 18, 2021 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 18, 2021 ALIE A ASSIGNED TO LIE Loading...
May 18, 2021 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
May 17, 2021 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
May 17, 2021 IUAA P USE AMENDMENT ACCEPTED Loading...
May 15, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 14, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 14, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 15, 2021 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
May 15, 2021 IUAF S USE AMENDMENT FILED Loading...
May 14, 2021 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Nov 16, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 16, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 16, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 13, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 12, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 13, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 13, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 13, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
medical treatment of cancer, infectious diseases, immune system-related diseases and disorders, and pathogen-induced diseases and disorders, namely, immunotherapies; antigen-directed cell therapy services
First Use Anywhere: May 12, 2020
First Use in Commerce: May 12, 2020

Classification

International Classes
044